Home・Akcijų sąrašas・ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

79.09 -0.63

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

77.72

Max

80.16

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-61K 27M
Pardavimai	-9.6M 237M
P/E Sektoriaus vid.	20.044 64.641
Pelnas, tenkantis vienai akcijai	1.68
Pelno marža	11.551
Darbuotojai	970
EBITDA	-20M 57M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+36.15% upside

Dividendai
By Acuity
Kitas uždarbis	2026-08-07

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-91M 1.8B
Ankstesnė atidarymo kaina	79.72
Ankstesnė uždarymo kaina	79.09

Naujienos nuotaikos

By Acuity

14%

86%

19 / 340 reitingas Healthcare

ANI Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-03 19:46; UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

2026-07-31 20:06; UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

2026-07-30 20:09; UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

2026-07-29 19:19; UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

2026-07-28 20:02; UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

2026-07-24 20:06; UTC

News

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

2026-07-22 20:01; UTC

News

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

2026-07-21 20:12; UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

2026-07-20 19:46; UTC

News

Social Media

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.

Akcijų palyginimas

Kainos pokytis

ANI Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

36.15% į viršų

12 mėnesių prognozė

Vidutinis 109 USD 36.15%

Aukščiausias 124 USD

Žemiausias 91 USD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines ANI Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

6 ratings

Pirkti

Laikyti

Parduoti

Remiantis 6 analitikų, pateikusių ANI Pharmaceuticals Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

19 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.